BioSpace News Archive

Business

CinCor Reports Fourth Quarter and Full-Year 2021 Financial Results and Provides Corporate Update

CinCor Pharma, Inc. (NASDAQ: CINC) today announced financial results for the fourth quarter and full-year ended December 31, 2021 and provided a corporate update.

March 22, 2022
·
13 min read
Business

Psychemedics Corporation Welcomes Drew Reynolds to Its Board of Directors and Announces the Retirement of Harry Connick From His Director Role

Psychemedics Corporation, the world’s largest provider of hair testing for drugs of abuse, is pleased to welcome Andrew “Drew” M. Reynolds to the Psychemedics Board of Directors effective April 4th, 2022.

March 22, 2022
·
5 min read
Genetown

Yield10 Bioscience to Present at the Maxim Group 2022 Virtual Growth Conference and Participate in Fireside Chat

Yield10 Bioscience, Inc. today announced that President and CEO Oliver Peoples, Ph.D. will participate at the Maxim Group 2022 Virtual Growth Conference, which is being held March 28-30, 2022.

March 22, 2022
·
1 min read
Business

Vect-Horus Strengthens its Scientific Advisory Board with the Appointment of Dr. Julia Alterman

Dr Alterman is currently an Assistant Professor at the RNA Therapeutics Institute, UMass Chan Medical School, where she focuses on siRNA chemical modification for extra-hepatic delivery.

March 22, 2022
·
2 min read
Oragenics Initiates a Pivotal IND-Enabling Toxicology Study on its Intranasal COVID-19 Vaccine Candidate, NT-CoV2-1

Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”) today announced the initiation of a Good Laboratory Practice (GLP) toxicology study to evaluate the safety profile and immunogenicity of its NT-CoV2-1 vaccine candidate in rabbits.

March 22, 2022
·
5 min read
BioMidwest

Satisfaction rates for virtual and in-person clinical care remain high among pediatric orthopaedic patients

Telemedicine and virtual office visits experienced exponential growth during the COVID-19 pandemic to help facilitate the safe delivery of orthopaedic care for numerous patient populations, including pediatric.

March 22, 2022
·
6 min read
Drug Development

Diadem Presents Data at AD/PD™ 2022 International Conference Demonstrating Its New AlzoSure® Confirm Blood Test Has the Potential to Accurately Diagnose Alzheimer’s Disease

Diadem srl announced that it presented data at the AD/PD™ 2022 International Conference on Alzheimer’s and Parkinson’s Diseases showing that its new AlzoSure® Confirm blood test can accurately identify patients with Alzheimer’s disease.

March 22, 2022
·
5 min read
Nanomerics Receives Further Upfront Payment for Anti-Viral Spray AnQlar(TM)

Nanomerics Ltd., a private speciality pharmaceutical company, announced the receipt of a further milestone payment on agreeing the expansion of its anti-viral spray licence to Virpax Pharmaceuticals.

March 22, 2022
·
3 min read
Policy

OBiO Technology Goes Public on Shanghai Stock Exchange Today

OBiO Technology Corp., Ltd., has completed its initial public offering process and started trading on the Shanghai Stock Exchange’s Sci-Tech innovation board.

March 22, 2022
·
2 min read
Policy

NIBIOHN Identifies Tissue-specific Exosome Marker Candidates from Blood

The National Institutes of Biomedical Innovation, Health and Nutrition based in Ibaraki-shi, Osaka Prefecture, has successfully catalogued more than 4,000 proteins contained in exosomes in healthy human blood.

March 22, 2022
·
2 min read